Internal Medicine Houston, Texas, United States of America
Connect with the speaker?
Dr. Jimenez is an Associate Professor of Endocrine Neoplasia and Hormonal Disorders. He has performed extensive clinical research in the field of endocrine cancer with a particular interest in pheochromocytomas and paragangliomas. Dr. Jimenez was one of the first clinicians to describe the use tyrosine kinase inhibitors in patients affected with sporadic and hereditary (Von Hippel-Lindau and Paraganglioma syndrome type 4) malignant pheochromocytomas and sympathetic paragangliomas. His observations led to the development of prospective multi-institutional, international clinical trials. Dr. Jimenez also characterized inherent complications related to excessive hormonal secretion and tumor burden distinctive of this disease.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)